Vraylar and Memantine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vraylar (cariprazine hydrochloride) and Memantine (memantine). Common drug interactions include drug ineffective among females and confusional state among males.

The phase IV clinical study analyzes what interactions people have when they take Vraylar and Memantine. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Vraylar?

Vraylar has active ingredients of cariprazine hydrochloride. eHealthMe is studying from 6,136 Vraylar users. Check the latest studies of Vraylar.

What is Memantine?

Memantine has active ingredients of memantine. It is often used in alzheimer's disease. eHealthMe is studying from 10,266 Memantine users. Check the latest studies of Memantine.

On Aug, 04, 2026

12 people who take Vraylar and Memantine together, and have interactions are studied.

Vraylar and Memantine drug interactions.

What are the common drug interactions of Vraylar and Memantine, by gender? *:

female:

Drug ineffective
Latent tuberculosis (hidden tuberculosis)
Suicidal ideation

male:

Confusional state
Anxiety
Dehydration (dryness resulting from the removal of water)
Hypoaldosteronism (decreased levels of the hormone aldosterone)
Obsessive-compulsive disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;)
Renal failure (kidney dysfunction)
Somnambulism (sleep walking)
Angiopathy (generic term for a disease of the blood vessels)
Arthralgia (joint pain)
Asthenia (weakness)

What are the common drug interactions of Vraylar and Memantine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Angiopathy (generic term for a disease of the blood vessels)
Anxiety
Arthralgia (joint pain)
Asthenia (weakness)
Chest pain
Depression
Disturbance in attention
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Hypersensitivity

30-39:

n/a

40-49:

Anxiety
Aspartate aminotransferase increased
Essential hypertension (primary hypertension)
Hypertension (high blood pressure)
Confusional state
Disturbance in attention
Hypercalcaemia (elevated calcium (ca+) level in the blood)
Hyperhidrosis (abnormally increased sweating)
Hypermetabolism (abnormal increase in the body's basal metabolic rate)
Night sweats (sweating in night)

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 58.33%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 16.67%
Constipation: 1 person, 8.33%
Breast Cancer Female: 1 person, 8.33%
Bipolar Disorder (mood disorder): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Vraylar and Memantine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously